Biomaterial Database

Local thrombolysis with recombinant tissue plasminogen activator in a high-risk patient. 1993

F Baudo, and G Brambilla, and F deCataldo, and A Rampoldi

UI	MeSH Term	Description	Entries
D008297	Male		Males
D010959	Tissue Plasminogen Activator	A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases.	Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011183	Postoperative Complications	Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.	Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011994	Recombinant Proteins	Proteins prepared by recombinant DNA technology.	Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368	Aged	A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available.	Elderly
D000369	Aged, 80 and over	Persons 80 years of age and older.	Oldest Old
D013927	Thrombosis	Formation and development of a thrombus or blood clot in BLOOD VESSELS.	Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D014682	Vena Cava, Inferior	The venous trunk which receives blood from the lower extremities and from the pelvic and abdominal organs.	Inferior Vena Cava,Inferior Vena Cavas,Vena Cavas, Inferior
D015912	Thrombolytic Therapy	Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.	Fibrinolytic Therapy,Thrombolysis, Therapeutic,Therapeutic Thrombolysis,Therapy, Fibrinolytic,Therapy, Thrombolytic,Fibrinolytic Therapies,Therapeutic Thrombolyses,Therapies, Fibrinolytic,Therapies, Thrombolytic,Thrombolyses, Therapeutic,Thrombolytic Therapies

Related Publications

F Baudo, and G Brambilla, and F deCataldo, and A Rampoldi

Thrombolysis with recombinant tissue plasminogen activator in 7 children.

September 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,

F Baudo, and G Brambilla, and F deCataldo, and A Rampoldi

Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with apixaban.

October 2014, International journal of stroke : official journal of the International Stroke Society,

F Baudo, and G Brambilla, and F deCataldo, and A Rampoldi

Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with rivaroxaban.

January 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,

F Baudo, and G Brambilla, and F deCataldo, and A Rampoldi

Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.

January 2010, Cerebrovascular diseases (Basel, Switzerland),

F Baudo, and G Brambilla, and F deCataldo, and A Rampoldi

Local intravenous thrombolysis with recombinant tissue plasminogen activator for salvage of forearm replantation.

November 1996, Journal of reconstructive microsurgery,